Pharmacokinetics of combined treatment with praziquantel and albendazole in neurocysticercosis

AIMS: Neurocysticercosis is the most common cause of acquired epilepsy in the world. Antiparasitic treatment of viable brain cysts is of clinical benefit, but current antiparasitic regimes provide incomplete parasiticidal efficacy. Combined use of two antiparasitic drugs may improve clearance of bra...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Garcia, Hector H, Lescano, Andres G, Lanchote, Vera L, Pretell, E Javier, Gonzales, Isidro, Bustos, Javier A, Takayanagui, Osvaldo M, Bonato, Pierina S, Horton, John, Saavedra, Herbert, Gonzalez, Armando E, Gilman, Robert H
Format: Artigo
Idioma:Inglês
Publicat: Blackwell Science Inc 2011
Matèries:
Pharmacokinetics
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3141188/
https://ncbi.nlm.nih.gov/pubmed/21332573
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2125.2011.03945.x
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars